Paxlovid (Nirmatrelvir/Ritonavir)

Paxlovid is an antiviral medication that combines two active ingredients: Nirmatrelvir and Ritonavir. It is specifically designed to treat mild to moderate COVID-19 in adults and pediatric patients who are at high risk for progressing to severe disease. The dual-action formula works by inhibiting viral replication, thereby reducing the severity and duration of the illness.

One of the key benefits of Paxlovid is its ability to decrease the risk of hospitalization or death from COVID-19. Clinical trials have demonstrated its efficacy, showing significant reductions in these outcomes among treated individuals compared to those who received a placebo.

Paxlovid is administered as a series of pills taken orally over five days. For optimal results, treatment should begin as soon as possible after the onset of COVID-19 symptoms, ideally within the first few days. This prompt initiation is crucial for maximizing its therapeutic effects.

While Paxlovid is generally well-tolerated, potential side effects may include altered taste, diarrhea, high blood pressure, and muscle aches. It is important for patients to discuss their complete medical history with healthcare providers, as there may be drug interactions, especially with certain medications that are metabolized by the liver.

Patients should also be aware that Paxlovid is not intended for use in those who are hospitalized due to severe COVID-19 or require oxygen therapy. It is a targeted treatment for those at higher risk of complications from the virus.

In summary, Paxlovid represents a significant advancement in the fight against COVID-19, offering a valuable treatment option for individuals at risk of severe illness. Its timely administration can lead to better health outcomes and contribute to the overall management of the pandemic.

• Nirmatrelvir


• Ritonavir

Paxlovid is an antiviral medication used to treat COVID-19 in individuals at high risk for severe disease. To use Paxlovid effectively, follow these detailed instructions:

1. Consult your healthcare provider to determine if Paxlovid is appropriate for your situation. It is typically prescribed for adults and pediatric patients aged 12 years and older who weigh at least 40 kg (88 lbs).




2. Ensure you start the treatment as soon as possible after a positive COVID-19 test result and within five days of symptom onset for maximum effectiveness.




3. Paxlovid consists of two medications: Nirmatrelvir and Ritonavir. You will receive a total of 30 pills: 20 Nirmatrelvir tablets and 10 Ritonavir tablets.




4. Take the medications exactly as prescribed by your healthcare provider. Typically, the dosing schedule involves taking three Nirmatrelvir tablets and one Ritonavir tablet together twice a day for five days.




5. Swallow the tablets whole with water. Do not crush, chew, or split the tablets, as this can affect how the medication works.




6. If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time.




7. Monitor for any side effects, which may include altered taste, diarrhea, high blood pressure, or muscle aches. If you experience severe reactions or worsening symptoms, contact your healthcare provider immediately.




8. Inform your healthcare provider about all medications you are currently taking, including over-the-counter drugs and supplements, as Paxlovid can interact with certain medications.




9. After completing the course of Paxlovid, continue to follow public health guidelines, such as wearing masks and practicing good hygiene, to prevent spreading COVID-19.

Always adhere to your healthcare provider's instructions and report any concerns during your treatment with Paxlovid.